• Je něco špatně v tomto záznamu ?

MyPal-Child study protocol: an observational prospective clinical feasibility study of the MyPal ePRO-based early palliative care digital system in paediatric oncology patients

M. Meyerheim, C. Karamanidou, S. Payne, T. Garani-Papadatos, A. Sander, J. Downing, K. Stamatopoulos, J. Ling, C. Payne, L. Scarfò, P. Lokaj, C. Maramis, N. Graf

. 2021 ; 11 (4) : e045226. [pub] 20210413

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018838

INTRODUCTION: Electronic patient-reported outcomes (ePROs) have tremendous potential to optimise palliative and supportive care for children with cancer, their families and healthcare providers. Particularly, these children and their families are subjected to multiple strains caused by the disease and its treatment. The MyPal digital health platform is designed to address these complex demands by offering pursuant ePRO-based functionalities via two mobile applications, one developed for children and the other for their parents. METHODS AND ANALYSIS: In this observational prospective feasibility study, 100 paediatric oncology patients aged between 6 and 17 years and at least one of their parents/legal guardians will be recruited at three clinical sites in two European countries (Germany and Czech Republic). They will use the mobile applications which are part of the novel digital health platform. During a 6-month study period, participants will complete various ePROs via the applications addressing quality of life, satisfaction with care and impact of the disease on the family at monthly intervals. Additionally, priority-based symptom reporting is integrated into a serious game for children. Outcomes that will be assessed concern the feasibility and the evaluation of the newly designed digital health platform to contribute to the evidence base of clinical ePRO use in paediatric oncology and palliative care process. ETHICS AND DISSEMINATION: The MyPal-Child study obtained ethical approval from the Ethics Committee responsible for the University of Saarland, that is, the Ärztekammer des Saarlandes, the Ethics Committee of the Medical School Hannover and the Ethics Committee of the University of Brno. Study results will be disseminated through scientific publications, presentations at international conferences, congresses and a final report to the European Commission. General publicly accessible information can be found on the project website (www.mypal-project.eu) and social media. TRIAL REGISTRATION NUMBERS: U1111-1251-0043, DRKS00021458, NCT04381221.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018838
003      
CZ-PrNML
005      
20210830100423.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/bmjopen-2020-045226 $2 doi
035    __
$a (PubMed)33849855
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Meyerheim, Marcel $u Clinic of Pediatric Oncology and Hematology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Saarland, Germany
245    10
$a MyPal-Child study protocol: an observational prospective clinical feasibility study of the MyPal ePRO-based early palliative care digital system in paediatric oncology patients / $c M. Meyerheim, C. Karamanidou, S. Payne, T. Garani-Papadatos, A. Sander, J. Downing, K. Stamatopoulos, J. Ling, C. Payne, L. Scarfò, P. Lokaj, C. Maramis, N. Graf
520    9_
$a INTRODUCTION: Electronic patient-reported outcomes (ePROs) have tremendous potential to optimise palliative and supportive care for children with cancer, their families and healthcare providers. Particularly, these children and their families are subjected to multiple strains caused by the disease and its treatment. The MyPal digital health platform is designed to address these complex demands by offering pursuant ePRO-based functionalities via two mobile applications, one developed for children and the other for their parents. METHODS AND ANALYSIS: In this observational prospective feasibility study, 100 paediatric oncology patients aged between 6 and 17 years and at least one of their parents/legal guardians will be recruited at three clinical sites in two European countries (Germany and Czech Republic). They will use the mobile applications which are part of the novel digital health platform. During a 6-month study period, participants will complete various ePROs via the applications addressing quality of life, satisfaction with care and impact of the disease on the family at monthly intervals. Additionally, priority-based symptom reporting is integrated into a serious game for children. Outcomes that will be assessed concern the feasibility and the evaluation of the newly designed digital health platform to contribute to the evidence base of clinical ePRO use in paediatric oncology and palliative care process. ETHICS AND DISSEMINATION: The MyPal-Child study obtained ethical approval from the Ethics Committee responsible for the University of Saarland, that is, the Ärztekammer des Saarlandes, the Ethics Committee of the Medical School Hannover and the Ethics Committee of the University of Brno. Study results will be disseminated through scientific publications, presentations at international conferences, congresses and a final report to the European Commission. General publicly accessible information can be found on the project website (www.mypal-project.eu) and social media. TRIAL REGISTRATION NUMBERS: U1111-1251-0043, DRKS00021458, NCT04381221.
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    _2
$a studie proveditelnosti $7 D005240
650    _2
$a lidé $7 D006801
650    12
$a nádory $x terapie $7 D009369
650    12
$a paliativní péče $7 D010166
650    _2
$a prospektivní studie $7 D011446
650    _2
$a kvalita života $7 D011788
651    _2
$a Česká republika $7 D018153
651    _2
$a Evropa $7 D005060
651    _2
$a Německo $7 D005858
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Karamanidou, Christina $u Institute of Applied Biosciences, Centre for Research and Technology-Hellas, Thessaloniki, Central Macedonia, Greece
700    1_
$a Payne, Sheila $u International Observatory on End of Life Care, Institute for Health Research, Lancaster University, Lancaster, Lancashire, UK
700    1_
$a Garani-Papadatos, Tina $u Department of Public Health Policy, University of West Attica, Athens, Attica, Greece
700    1_
$a Sander, Annette $u Clinic for Paediatric Oncology and Haematology, Hannover Medical School, Hannover, Niedersachsen, Germany
700    1_
$a Downing, Julia $u International Children's Palliative Care Network, Bristol, Avon, UK
700    1_
$a Stamatopoulos, Kostas $u Institute of Applied Biosciences, Centre for Research and Technology-Hellas, Thessaloniki, Central Macedonia, Greece
700    1_
$a Ling, J $u Head Office, European Association for Palliative Care, Vilvoorde, Belgium
700    1_
$a Payne, Cathy $u Head Office, European Association for Palliative Care, Vilvoorde, Belgium
700    1_
$a Scarfò, Lydia $u Department of Onco-Haematology, Division of Experimental Oncology, Università Vita Salute San Raffaele, Milano, Italy
700    1_
$a Lokaj, Petr $u Department of Pediatric Oncology, University Hospital Brno, Brno, Jihomoravský, Czech Republic
700    1_
$a Maramis, Christos $u Institute of Applied Biosciences, Centre for Research and Technology-Hellas, Thessaloniki, Central Macedonia, Greece
700    1_
$a Graf, Norbert $u Clinic of Pediatric Oncology and Hematology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Saarland, Germany graf@uks.eu
773    0_
$w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 11, č. 4 (2021), s. e045226
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33849855 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100423 $b ABA008
999    __
$a ok $b bmc $g 1689813 $s 1139284
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 4 $d e045226 $e 20210413 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

    Možnosti archivace